To further illustrate the expression of YTHDF3, we selected 345 pairs of lung adenocarcinoma patients, 50 pairs of esophageal cancer patients, and 30 pairs of thymoma patients to monitor the immune response in cancer tissues and adjacent tissues by ELISAs. Here, YTHDF3 is linked to esophageal cancer.